111.27
0.22%
0.215
Zimmer Biomet Holdings Inc stock is traded at $111.27, with a volume of 334.16K.
It is up +0.22% in the last 24 hours and up +5.59% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$111.05
Open:
$111.72
24h Volume:
334.16K
Relative Volume:
0.22
Market Cap:
$22.11B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
21.15
EPS:
5.26
Net Cash Flow:
$1.26B
1W Performance:
+0.26%
1M Performance:
+5.59%
6M Performance:
-0.07%
1Y Performance:
-9.05%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
111.25 | 22.11B | 7.60B | 1.08B | 1.26B | 5.26 |
ABT
Abbott Laboratories
|
128.14 | 221.77B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
103.91 | 151.38B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
394.23 | 149.08B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
92.11 | 117.21B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.59 | 41.95B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Upgrade | JP Morgan | Neutral → Overweight |
Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
May-30-24 | Initiated | Goldman | Neutral |
May-21-24 | Upgrade | Argus | Hold → Buy |
Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
Oct-20-23 | Initiated | ROTH MKM | Neutral |
Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
Mar-29-23 | Initiated | UBS | Sell |
Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Oct-18-22 | Initiated | Barclays | Underweight |
Oct-12-22 | Initiated | Jefferies | Underperform |
May-27-22 | Downgrade | Needham | Buy → Hold |
Apr-13-22 | Downgrade | Truist | Buy → Hold |
Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
Mar-02-22 | Resumed | BofA Securities | Underperform |
Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
Feb-08-22 | Reiterated | Citigroup | Buy |
Feb-08-22 | Reiterated | Deutsche Bank | Hold |
Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
Feb-08-22 | Reiterated | JP Morgan | Neutral |
Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
Feb-08-22 | Reiterated | Stifel | Buy |
Feb-08-22 | Reiterated | Truist | Buy |
Feb-08-22 | Reiterated | UBS | Neutral |
Feb-08-22 | Reiterated | Wells Fargo | Underweight |
Feb-02-22 | Downgrade | UBS | Buy → Neutral |
Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
Dec-07-21 | Initiated | Loop Capital | Buy |
Nov-23-21 | Downgrade | Argus | Buy → Hold |
Sep-14-21 | Resumed | Raymond James | Mkt Perform |
May-25-21 | Initiated | Barclays | Overweight |
Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
Dec-18-20 | Reiterated | Needham | Strong Buy |
Oct-20-20 | Initiated | Northland Capital | Market Perform |
Sep-11-20 | Initiated | Wolfe Research | Outperform |
Aug-05-20 | Reiterated | Needham | Strong Buy |
Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
Apr-07-20 | Reiterated | Needham | Strong Buy |
Mar-05-20 | Initiated | Citigroup | Buy |
Feb-13-20 | Initiated | Goldman | Buy |
Jan-08-20 | Initiated | SunTrust | Buy |
Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
Aug-12-19 | Upgrade | Argus | Hold → Buy |
Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Gries Financial LLC Purchases Shares of 8,196 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Paragon 28 stock rating cut to Equal Weight by Stephens - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid expansion and ERP challenges - Investing.com
Zimmer Biomet buying Paragon 28 for $1.1B to bolster F&A offerings - BioWorld Online
Zimmer Biomet reaches agreement to acquirement Colorado-based medical device company - Fort Wayne Journal Gazette
FNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paragon 28, Inc. Is Fair to Shareholders - Business Wire
Zimmer Biomet to buy Paragon 28 for $1.2B - Mass Device
Paragon 28 stock rating downgraded to Hold at Needham - MSN
Paragon 28 Shares Rise After Zimmer Biomet Buyout Deal - MarketWatch
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business - MSN
Latham & Watkins Advises on Zimmer Biomet’s Acquisition of Paragon 28 - Latham & Watkins LLP
Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal - GuruFocus.com
Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn - Medical Device Network
Needham & Company LLC Reiterates Hold Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (ZBH) Announces Merger Agreement with Par - GuruFocus.com
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details - Yahoo Finance
Zimmer Biomet to Acquire Paragon 28 for $1.2 Billion - TipRanks
Zimmer Biomet acquires Paragon 28 at $13/share By Investing.com - Investing.com UK
Zimmer Biomet set to acquire Paragon 28 for $1.1 billion By Investing.com - Investing.com UK
Zimmer Biomet to acquire Paragon 28 for $13.00 per share in cash upfront - TipRanks
Zimmer Biomet to acquire Paragon 28 for $1.1 bln By Investing.com - Investing.com Australia
Zimmer Biomet to acquire Paragon 28 for $1.1 bln - Investing.com
Zimmer Biomet to buy Paragon 28 for $1.1 billion - Reuters
Zimmer Biomet to buy Paragon 28 for $1.1 billion -January 28, 2025 at 06:11 pm EST - Marketscreener.com
Zimmer Biomet to acquire Paragon 28 for $1.1 billion - PharmaLive
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 - PR Newswire
Matrix Asset Advisors Inc. NY Has $9.53 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. entered into a definitive agreement to acquire Paragon 28, Inc. for $1.1 billion - Marketscreener.com
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Merit Financial Group LLC Has $387,000 Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Gradient Investments LLC Grows Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet : Conformis Settles Patent Dispute With Zimmer Biomet -May 28, 2020 at 08:03 am EDT - Marketscreener.com
Stifel Nicolaus Forecasts Strong Price Appreciation for Zimmer Biomet (NYSE:ZBH) Stock - Defense World
Zimmer Biomet (NYSE:ZBH) Shares Gap Up After Analyst Upgrade - Defense World
Zimmer Biomet (NYSE:ZBH) Shares Gap Up on Analyst Upgrade - MarketBeat
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $138.00 at Stifel Nicolaus - MarketBeat
Stifel raises Zimmer Biomet stock target to $138 on strong outlook - MSN
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On An Uptrend: Could Fundamentals Be Driving The Stock? - Simply Wall St
SG Americas Securities LLC Sells 109,084 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Hip and Knee Reconstructive Market to Reach USD 41,071.4 Million by 2035, Growing at a 5.6% CAGR from 2025 to 2035 | FMI - GlobeNewswire Inc.
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock - Benzinga
Zacks Research Cuts Earnings Estimates for Zimmer Biomet - Defense World
Stifel raises Zimmer Biomet stock target to $138 on strong outlook By Investing.com - Investing.com South Africa
Zacks Research Forecasts Lower Earnings for Zimmer Biomet - MarketBeat
Roberts Wealth Advisors LLC Makes New $1.95 Million Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Assenagon Asset Management S.A. Raises Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report - MSN
Emerging Market Expansion Supports ZBH Stock Amid Macro Issues - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Lmcg Investments LLC - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by MassMutual Private Wealth & Trust FSB - MarketBeat
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):